
Judges Scientific plc
("Judges Scientific", "Judges" or the "Company")
Board Change and formation of Executive Committee
Judges Scientific, the group focused on acquiring and developing companies in the scientific instrument sector, announces the following change to the Board and management structure of the Group.
Mark Lavelle, Chief Operating Officer, has advised the Board of his intention to retire by September 2026, when he will be 68. As part of his move towards retirement, Mark has decided to step down from the Board at the Annual General Meeting on 22 May 2025 and not offer himself for re-election.
Mark will be stepping down from his individual subsidiary responsibilities, enabling him to focus on helping all the Group's companies further improve their operational, analytical, talent development, and international capabilities.
Additionally, the Group is evolving its internal structure by forming an Executive Committee, reporting to the Board. The Executive Committee will be responsible for the management of the Group and will include the Executive Directors and further key members of the Company's senior leadership team as required. Mark will be a key member of the Executive Committee until his retirement.
Mark Lavelle, Chief Operating Officer, commented: "In my seven and a half years at Judges so far, it has been a real privilege to be able to combine the knowledge gained in my degree and early career in Science and Instrumentation, with the commercial focus that I developed such a passion for over the 25 years before Judges: finding, leading and enhancing wonderful, niche, independent SMEs. To do so under the scrupulously honest and ethical leadership of David Cicurel, alongside our outstanding developing Executive team, and with such a wonderful group of staff at all levels across the Group, has only added to the pleasure that every day of the COO role has brought me."
David Cicurel, Chief Executive Officer, commented: "Mark has had an enormous influence on the development and success of the Group's excellent portfolio of businesses and I, on behalf of the entire Board, thank him for his decisive contribution over much of the last decade. We are delighted that he will continue to contribute to the ongoing performance of the Group's businesses and their growth trajectory via our newly constituted Executive Committee."
For further information please contact:
Judges Scientific plc David Cicurel, CEO Brad Ormsby, CFO Tel: +44 (0) 20 3829 6970
| Shore Capital (Nominated Adviser & Joint Broker) Stephane Auton Harry Davies-Ball Tel: +44 (0) 20 7408 4090
| |
Panmure Liberum (Joint Broker) Edward Mansfield Nikhil Varghese Josh Borlant Tel : +44 (0) 20 3100 2222
| Investec Bank plc (Joint Broker) Virginia Bull Carlton Nelson Tel: +44 (0) 20 7597 4000 | |
Alma (Financial Public Relations) Sam Modlin Rebecca Sanders-Hewett Joe Pederzolli Sarah Peters Tel: +44 (0) 20 3405 0205 | | |
Notes to editors:
Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group consists of 25 businesses acquired since 2005.
The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queen's Awards for innovation and export.
The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.
Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the reduction of debt, organic growth and dividends.
For further information, please visit www.judges.uk.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.